Eletriptan Hydrobromide
16 NDCs across 7 manufacturers|11 Generic,5 Brand
Eletriptan Hydrobromide is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 26, 2002, and the first generic was approved Jun 16, 2017. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $9 million on Eletriptan Hydrobromide across 70,000 claims for 17,000 beneficiaries.
Eletriptan Hydrobromide is available as 16 NDCs from 7 manufacturers (11 generic, 5 brand), with NADAC prices from $1.91 to $77.43 per EA — the most expensive product costs about 41× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
11G / 5B
Manufacturers
7
competing in market
Price Spread
$1.91 – $77.43
per EA
7d Activity
avg -6.1% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
7 manufacturers producing ELETRIPTAN HYDROBROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RELPAX 20 MG TABLET | $77.4338 per EA | +0.02% |
RELPAX 20 MG TABLET | $77.4338 per EA | +0.02% |
RELPAX 40 MG TABLET | $77.1444 per EA | — |
RELPAX 40 MG TABLET | $77.0802 per EA | -0.01% |
RELPAX 40 MG TABLET | $77.0802 per EA | -0.01% |
ELETRIPTAN HBR 20 MG TABLET | $1.9354 per EA | -15.37% |
ELETRIPTAN HBR 20 MG TABLET | $1.9354 per EA | -15.37% |
ELETRIPTAN HBR 20 MG TABLET | $1.9354 per EA | -15.37% |
ELETRIPTAN HBR 20 MG TABLET | $1.9354 per EA | -15.37% |
ELETRIPTAN HBR 20 MG TABLET | $1.9354 per EA | -15.37% |
ELETRIPTAN HBR 40 MG TABLET | $1.9092 per EA | -2.52% |
ELETRIPTAN HBR 40 MG TABLET | $1.9092 per EA | -2.52% |
ELETRIPTAN HBR 40 MG TABLET | $1.9092 per EA | -2.52% |
ELETRIPTAN HBR 40 MG TABLET | $1.9092 per EA | -2.52% |
ELETRIPTAN HBR 40 MG TABLET | $1.9092 per EA | -2.52% |
ELETRIPTAN HBR 40 MG TABLET | $1.9092 per EA | -2.52% |
Frequently Asked Questions
What is Eletriptan Hydrobromide used to treat?
Eletriptan Hydrobromide is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
When did Eletriptan Hydrobromide become available as a generic?
FDA approved the first generic Eletriptan Hydrobromide (ANDA) on Jun 16, 2017. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Eletriptan Hydrobromide?
In 2024, Medicare Part D spent $9 million on Eletriptan Hydrobromide across 70,000 claims for 17,000 beneficiaries.
How many Eletriptan Hydrobromide products are on the market?
The Eletriptan Hydrobromide drug market contains 16 NDCs from 7 manufacturers — 11 generic and 5 brand products.
What is the price range for Eletriptan Hydrobromide?
NADAC reference prices for Eletriptan Hydrobromide range from $1.9092 to $77.4338 per EA — the most expensive product costs about 41× the cheapest.
Is generic Eletriptan Hydrobromide cheaper than brand?
The average generic NADAC for Eletriptan Hydrobromide is $1.9211 per EA, versus $77.2345 for brand-labeled products — brand versions average about 40× the generic price.
Which manufacturers make Eletriptan Hydrobromide?
7 manufacturers list Eletriptan Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (3), Mylan Pharmaceuticals Inc. (3), Roerig (2), Teva Pharmaceuticals USA Inc. (2), Camber Pharmaceuticals Inc. (2).
How has the price of Eletriptan Hydrobromide changed recently?
Over the past 7 days, 2 Eletriptan Hydrobromide NDCs rose and 13 fell, with a market-wide average change of -6.1%.